Gender differences in substance use patterns and disorders among an Iranian patient sample receiving methadone maintenance treatment

Authors

  • Morad Rasouli-Azad Ph.D. of Clinical Psychology, Assistant Professor, Department of Clinical Psychology, School of Medicine, Kashan University of Medical Science, Kashan, Iran , Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran

Keywords:

Iran, Gender, Opioid substitution treatment, Substance-related disorder, Methadone

Abstract

Background: The current prevalence rate of substance abuse and dependence, represents an increasing trend of substance abuse and dependence among women, and the results of epidemiology studies indicate that substance use patterns are different between men and women. This study aimed to determine gender differences in substance use patterns and disorders among the patients undergoing methadone maintenance treatment.

Methods: This cross-sectional study was conducted throughout a specified time bracket ranging from September 2012 through March 2013 in Methadone Maintenance Treatment (MMT) clinics of Mashhad, Iran. In this study, 140 men and 120 women were selected from among the patients referring to MMT clinics in Mashhad through purposeful sampling method. The sample units were assessed using a demographic information questionnaire and Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (SCID). The data were then analyzed by Chi Square test, Mann-Whitney U test, and Independent-samples t-test. SPSS software 16 was used to conduct statistical analyses with P values less than 0.05 regarded as significant.

Results: The results showed that men and women are significantly different from each other in terms of marital status (p=0.001), education (p=0.001), income (p=0.001), history of injection (p=0.002), imprisonment (p=0.001), and substance use abstention (p=0.023). It was also revealed that methamphetamine dependence (p=0.017) and simultaneous use of multiple substances (p=0.001) in the past 12 months were diagnosed, to a larger extent, in male participants than those in female participants. In addition, the diagnoses of nicotine dependence (p=0.001), cannabis abuse (p=0.001), heroin dependence (p=0.001), and substance abuse and alcohol dependence (p=0.001) during a lifetime were more frequently existing in males than those in females.

Conclusion: There are gender differences in substance use patterns and disorders that appear to be caused by the degree of access to substances and the impacts of cultural and social aspects on men and women in Iran.

 

References

United Nations Office on Drugs, Crime. World drug report. United Nations Publications; 2016.

Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al.

Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service

utilization results from the Iranian Mental Health Survey. Addiction. 2016; 111(10): 1836-47. doi:

1111/add.13453. PMID: 27177849.

Eskandarieh S, Hajebi A, Noroozi A, Haghdoost AA, Baneshi MR. Epidemiology of Alcohol Abuse in

Iran. Asia Pac J Med Toxicol. 2014; 3: 22. doi: 10.22038/APJMT.2014.2905.

Bagheri Lankarani K, Alavian SM, Peymani P. Health in the Islamic Republic of Iran, challenges and

progresses. Med J Islam Repub Iran. 2013; 27(1): 42-9. PMID: 23479501, PMCID: PMC3592943.

Lankarani KB, Afshari R. Alcohol consumption in Iran. Lancet. 2014; 384(9958): 1927-8. doi:

1016/S0140-6736(14)62279-0. PMID: 25435451.

Alam-Mehrjerdi Z, Daneshmand R, Samiei M, Samadi R, Abdollahi M, Dolan K. Women-only drug

treatment services and needs in Iran: the first review of current literature. Daru. 2016; 24(1): 1. doi:

1186/s40199-016-0141-1. PMID: 26893096.

Tavakoli M, Mohammadi L, Yarmohammadi M, Farhoudian A, Ja'fari F, Farhadi MH. Status and trend of

substance abuse and dependence among Iranian women. Journal of Rehabilitation. 2014; 14(5): 30-7.

Johnston LD, O’Malley PM, Bachman JG. Monitoring the future: National survey results on drug use,

–2001: Volume II. College students and adults ages 19–40. Washington, DC: U.S. Government

Printing Office, NIH Publication; 2002: 5102-7.

Van Etten ML, Anthony JC. Male–female differences in transitionsfrom first drug opportunity to first use:

searching for subgroup variation by age, race, region, and urban status. J Womens Health Gend Based Med.

; 10(8): 797–804. doi: 10.1089/15246090152636550. PMID: 11703892.

Kim JY, Fendrich M. Gender differences in juvenile arrestees’drug use, self-reported dependence, and

perceived need for treatment. Psychiatr Serv. 2002; 53(1): 70-5. doi: 10.1176/appi.ps.53.1.70. PMID:

Lex B. Some gender differences in alcohol and polysubstance users. Health Psychol. 1991; 10(2): 121–32.

doi: 10.1037/0278-6133.10.2.121. PMID: 2055210.

Merikangas KR, McClair VL. Epidemiology of substance use disorders. Hum Genet. 2012; 131(6): 779-89.

doi: 10.1007/s00439-012-1168-0. PMID: 22543841.

Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am.

; 33(2): 339-55. doi: 10.1016/j.psc.2010.01.004. PMID: 20385341.

Beaudoin FL, Baird J, Liu T, Merchant RC. Sex Differences in Substance Use Among Adult Emergency

Department Patients: Prevalence, Severity, and Need for Intervention. Acad Emerg Med. 2015; 22(11):

-15. doi: 10.1111/acem.12810. PMID: 26473942.

Hammerslag LR, Gulley JM. Sex differences in behavior and neural development and their role in

adolescent vulnerability to substance use. Behav Brain Res. 2016; 298: 15-26. doi:

1016/j.bbr.2015.04.008. PMID: 25882721.

Ziaaddini H, Ziaaddini MR. The household survey of drug abuse in Kerman, Iran. J appl sciences. 2005;

(2): 380-2. doi: 10.3923/jas.2005.380.382.

Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Mokri A. The establishment of a methadone treatment

clinic for women in Tehran, Iran. J Public Health Policy. 2011; 32(2): 219-30. doi: 10.1057/jphp.2011.10.

PMID: 21390074.

Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A. Characteristics of Iranian women

seeking drug treatment. J Womens Health. 2011; 20(11): 1687-91. doi: 10.1089/jwh.2010.2694. PMID:

Hojjat SK, Hatami SE, Rezaei M, Hamidi M, Khalili MN. Women in opioid maintenance treatment in Iran:

Background characteristics and history of substance use and risk behaviors. J Subst Use. 2016:1-7.

Sharifi V, Assadi SM, Mohammadi MR, Amini H, Kaviani H, Semnani Y, et al. A persian translation of

the structured clinical interview for diagnostic and statistical manual of mental disorders: psychometric

properties. Compr Psychiatry. 2009; 50(1): 86-91. doi: 10.1016/j.comppsych.2008.04.004. PMID:

Zolala F, Mahdavian M, Haghdoost AA, Karamouzian M. Pathways to Addiction: A Gender-Based Study

on Drug Use in a Triangular Clinic and Drop-in Center, Kerman, Iran. Int J High Risk Behav Addict. 2016;

(2). doi: 10.5812/ijhrba.22320. PMID: 27622164.

Zhang Y, Lu C, Zhang J, Hu L, Song H, Li J, et al. Gender differences in abusers of amphetamine-type

stimulants and ketamine in southwestern China. Addict Behav. 2013; 38(1): 1424-30. doi:

1016/j.addbeh.2012.06.024. PMID: 23006246.

Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug

treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct

J. 2012; 9(1): 18. doi: 10.1186/1477-7517-9-18. PMID: 22676557.

McHugh RK, DeVito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, et al. Gender differences in a

clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013; 45(1): 38-43. doi:

1016/j.jsat.2012.12.007. PMID: 23313145.

Moore LV, Thompson FE. Adults meeting fruit and vegetable intake recommendations—United States,

MMWR Morb Mortal Wkly Rep. 2015; 64(26): 709-13. PMID: 26158351.

Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, et al. Epidemiology of DSM-5 drug use

disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions–III. JAMA

psychiatry. 2016; 73(1): 39-47. doi: 10.1001/jamapsychiatry.2015.2132. PMID: 26580136.

Eitle TM, Eitle D. Explaining the Association between Gender and Substance Use among American Indian

Adolescents An Application of Power-control Theory. Sociol Perspect. 2015; 58(4): 686-710. doi:

1177/0731121415570394. PMID: 27313337.

Maremmani I, Stefania C, Pacini M, Maremmani AG, Carlini M, Golia F, et al. Differential substance

abuse patterns distribute according to gender in heroin addicts. J Psychoactive Drugs. 2010; 42(1): 89-95.

doi: 10.1080/02791072.2010.10399789. PMID: 20464810.

Merle GS. Women & addiction: GenderIssues in Abuse and Treatment. 2002. Available from:

http://www.caron.org/pdf/Wmn&Addctn-GenderIssues.

Kuhn C. Emergence of sex differences in the development of substance use and abuse during adolescence.

Pharmacol Ther. 2015; 153: 55-78. doi: 10.1016/j.pharmthera.2015.06.003. PMID: 26049025.

Adam A, Faouzi M, Yersin B, Bodenmann P, Daeppen JB, Bertholet N. Women and men admitted for

alcohol intoxication at an emergency department: alcohol use disorders, substance use and health and social

status 7 years later. Alcohol Alcohol. 2016; 51(5): 567-75. doi: 10.1093/alcalc/agw035. PMID: 27358186.

Fernández-Artamendi S, Secades-Villa R, FernándezHermida JR, García-Fernández G, García-Rodríguez

O. Gender differences in early alcohol and tobacco use as a risk factor in Spanish adolescents. Subst Use

Misuse. 2013; 48(6): 429-37. doi: 10.3109/10826084.2013.776085. PMID: 23517404.

Çiftçi Demirci A, Erdoğan A, Yalçın Ö, Yıldızhan E, Koyuncu Z, Eseroğlu T, et al. Sociodemographic

characteristics and drug abuse patterns of adolescents admitted for substance use disorder treatment in

Istanbul. Am J Drug Alcohol Abuse. 2015; 41(3): 212-9. doi: 10.3109/00952990.2014.973961. PMID:

Colell E, Sánchez-Niubò A, Domingo-Salvany A. Sex differences in the cumulative incidence of substance

use by birth cohort. Int J Drug Policy. 2013; 24(4): 319-25. doi: 10.1016/j.drugpo.2012.09.006. PMID:

Rojas JI, Hallford G, Brand MW, Tivis LJ. Latino/as in substance abuse treatment: substance use patterns,

family history of addiction, and depression. J Ethn Subst Abuse. 2012; 11(1): 75-85. doi:

1080/15332640.2012.652530. PMID: 22381124.

Kandel DB, Yamaguchi K, Chen K. Stages of progression in drug involvement from adolescence to

adulthood: further evidence for the gateway theory. J Stud Alcohol. 1992; 53(5): 447-57. doi:

15288/jsa.1992.53.447. PMID: 1405637.

Nikfarjam A, Shokoohi M, Shahesmaeili A, Haghdoost AA, Baneshi MR, Haji-Maghsoudi S, et al.

National population size estimation of illicit drug users through the network scale-up method in 2013 in

Iran. Int J Drug Policy. 2016; 31: 147-52. doi: 10.1016/j.drugpo.2016.01.013. PMID: 26980349.

Rahimi-Movaghar A, Amin-Esmaeili M, Shadloo B, Noroozi A, Malekinejad M. Transition to injecting

drug use in Iran: A systematic review of qualitative and quantitative evidence. Int J Drug Policy. 2015;

(9): 808-19. doi: 10.1016/j.drugpo.2015.04.018. PMID: 26210009.

Larney S, Cama E, Nelson E, Larance B, Degenhardt L. A cross-sectional study of correlates of

imprisonment in opioid-dependent men and women in New South Wales, Australia. Drug Alcohol Rev.

; 35(6): 686-92. doi: 10.1111/dar.12357. PMID: 26711174, PMCID: PMC4927415.

Haughwout SP, Harford TC, Castle IJP, Grant BF. Treatment Utilization Among Adolescent Substance

Users: Findings from the 2002 to 2013 National Survey on Drug Use and Health. Alcohol Clin Exp Res.

; 40(8): 1717-27. doi: 10.1111/acer.13137. PMID: 27427179.

Manuel JI, Stebbins MB, Wu E. Gender Differences in Perceived Unmet Treatment Needs Among Persons

With and Without Co-occurring Disorders. J Behav Health Serv Res. 2016: 1-12. doi: 10.1007/s11414-016- 9530-y. PMID: 27507243.

Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iranian Med. 2002; 5(3): 184-90.

Lewis B, Nixon SJ. Characterizing gender differences in treatment seekers. Alcohol Clin Exp Res. 2014;

(1): 275-84. doi: 10.1111/acer.12228. PMID: 23930695.

Lewis B, Hoffman LA, Nixon SJ. Sex differences in drug use among polysubstance users. Drug Alcohol

Depend. 2014; 145: 127-33. doi: 10.1016/j.drugalcdep.2014.10.003. PMID: 25454410.

Chou SP, Goldstein RB, Smith SM, Huang B, Ruan WJ, Zhang H, et al. The epidemiology of DSM-5

nicotine use disorder: results from the National Epidemiologic Survey on Alcohol and Related ConditionsIII. J Clin Psychiatry. 2016; 77(10): 1404-12. doi: 10.4088/JCP.15m10114. PMID: 27135834.

Redonnet B, Chollet A, Fombonne E, Bowes L, Melchior M. Tobacco, alcohol, cannabis and other illegal

drug use among young adults: the socioeconomic context. Drug Alcohol Depend. 2012; 121(3): 231-9. doi:

1016/j.drugalcdep.2011.09.002. PMID: 21955362.

Hashem Abadi BA, Azad MR, Saed O. Prevalence, Patterns, and Socio-Demographic Correlates of

Nicotine Use in a Sample of Iranian University Students. Int J High Risk Behav Addict. 2012; 1(1): 27-33.

Mahfouz MS, Alsanosy RM, Gaffar AM, Makeen A. Tobacco use among university students of Jazan

Region: gender differences and associated factors. Biomed Res Int. 2014; 2014:279231. doi:

1155/2014/279231. PMID: 24900961, PMCID: PMC4036415.

Mandil A, Bin Saeed A, Dabbagh R, Shaikh SA, Al Saadi M, Khan M. Smoking among Saudi university

students: consumption patterns and risk factors. East Mediterr Health J. 2011; (4): 309-16. PMID:

Organization WH. WHO report on the global tobacco epidemic, 2011: warning about the dangers of

tobacco. World Health Organization; 2011.

Mahalik JR, Lombardi CM, Sims J, Coley RL, Lynch AD. Gender, male-typicality, and social norms

predicting adolescent alcohol intoxication and marijuana use. Soc Sci Med. 2015; 143: 71-80. doi:

1016/j.socscimed.2015.08.013. PMID: 26344125.

Khan SS, Secades-Villa R, Okuda M, Wang S, Pérez-Fuentes G, Kerridge BT, et al. Gender differences in

cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions.

Drug Alcohol Depend. 2013; 130(1): 101-8. doi: 10.1016/j.drugalcdep.2012.10.015. PMID: 23182839.

Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: Findings from the National

Survey on Drug Use and Health. Addict Behav. 2010; 35(11): 1001-7. doi: 10.1016/j.addbeh.2010.06.018.

PMID: 20598809.

Shariatirad S, Maarefvand M, Ekhtiari H. Emergence of a methamphetamine crisis in Iran. Drug Alcohol

Rev. 2013; 32(2): 223-4. doi: 10.1111/dar.12014. PMID: 23190186.

Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an

emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013; 24(6): e115-6.

doi: 10.1016/j.drugpo.2013.05.003. PMID: 23773684.

Delva J, Lee W, Sanchez N, Andrade FH, Grogan-Kaylor A, Sanhueza G, et al. Ecological factors and

adolescent marijuana use: results of a prospective study in Santiago, Chile. Int J Environ Res Public Health.

; 11(3): 3443-52. doi: 10.3390/ijerph110303443. PMID: 24662965.

Lev-Ran S, Le Strat Y, Imtiaz S, Rehm J, Le Foll B. Gender differences in prevalence of substance use

disorders among individuals with lifetime exposure to substances: results from a large representative

sample. Am J Addict. 2013; 22(1): 7-13. doi: 10.1111/j.1521-0391.2013.00321.x. PMID: 23398220.

Published

2022-02-12